Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-235651 and 333-162702 of GlaxoSmithKline PLC on Form S-8 of our report dated June 11, 2024, relating to the financial statements and supplemental schedule of the GSK 401(k) Plan, appearing in this Annual Report on Form 11-K of the GSK 401(k) Plan for the year ended December 31, 2023.
/s/ DELOITTE & TOUCHE LLP
Philadelphia, Pennsylvania
June 11, 2024
